The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Success Stories From Small Molecule Drug Product Significant progress in CM implementation has been made over the last ten years. From fundamental studies within academia to global drug product CM approvals, CM represents a paradigm shift within the industry that will continue to grow with time. In this session, success stories from some of the early adopters and implementers will be shared which include regulatory, technical, and business-related achievements in the hope that it will encourage others to join the CM movement!
Leveraging Continuous Manufacturing to Enable Real Time Release Testing
Joseph Medendorp, Senior Director, Technical Operations
Vertex
Particle Design and Engineering to Enable Continuous Direct Compression Manufacturing Processes
Jeremy Merritt, PhD, Principal Research Scientist, Particle Design Lab – Small Molecule Design & Development
Eli Lilly and Company Janssen
CM-strategy: A Story of Multiple Platforms From R&D to Commercial
Jeroen Geens, Engineering Technical Director – New Platforms
Janssen
Moderator(s):
Wyatt
Roth,
PhD,
Senior Research Scientist,
Eli Lilly and Company
Speaker(s):
Joseph
Medendorp,
PhD,
Senior Director, Technical Operations,
Vertex
Jeremy
Merritt,
PhD,
Principal Research Scientist,
Eli Lilly and Company
Jeroen
Geens,
PhD,
Engineering Technical Director, New Platforms,
Janssen Research & Development
Credits
Credits: None available.
You must be logged in and own this session in order to
post comments.